Delivery Order SPE2DB20D3103-SPE2DB25FL3E0
Award Date
10/9/24
Potential Completion Date
10/10/24
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,791.68 firm-fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4565712536 OLUMIANT 4 MG TABLET 30S, a prescription medication. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,813.16, is for the delivery of Olumiant 4 MG tablets. It is a firm fixed price, delivery order contract with an ultimate completion date of October 25, 2024. This contract is a child award under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,272.35 firm fixed-price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $4,062.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, a medical product, with a period of performance through February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $82,443.07 for the delivery of Olumiant 4 mg tablets. The contract has a period of performance through September 25, 2024 and is structured as a firm-fixed-price arrangement. This delivery order is placed against an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific contract award is for the delivery of 4567156621 - OLUMIANT 4 MG...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FL6Y5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $26,950.70, is for the delivery of OLUMIANT 4 MG TABLET 30S, a medication, to support military healthcare programs. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,962.58 and a completion date of January 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, and it is part...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,504.84 Firm Fixed Price Delivery Order contract is for the supply of OLUMIANT 4 MG TABLET 30S, a medication used for various medical conditions. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Olumiant 2 mg tablets, a pharmaceutical product, to support federal healthcare programs. The delivery order has a ceiling value of $3,359.07 and a completion date of August 7, 2024. This contract is not set aside for any particular business type. AmerisourceBergen, a major pharmaceutical...